162 related articles for article (PubMed ID: 33812160)
1. The relationship between brain-derived neurotrophic factor and metabolic syndrome in patients with chronic schizophrenia: A systematic review.
Kalejahi P; Kheirouri S; Noorazar SG; Sanayei M
Neuropeptides; 2021 Jun; 87():102135. PubMed ID: 33812160
[TBL] [Abstract][Full Text] [Related]
2. Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results.
Zhang Y; Chen M; Wu Z; Chen J; Yu S; Fang Y; Zhang C
PLoS One; 2013; 8(8):e72652. PubMed ID: 23967328
[TBL] [Abstract][Full Text] [Related]
3. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.
Zhang Y; Chen M; Chen J; Wu Z; Yu S; Fang Y; Zhang C
Psychopharmacology (Berl); 2014 May; 231(10):2211-8. PubMed ID: 24448899
[TBL] [Abstract][Full Text] [Related]
5. Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.
Yang F; Wang K; Du X; Deng H; Wu HE; Yin G; Ning Y; Huang X; Teixeira AL; de Quevedo J; Soares JC; Li X; Lang X; Zhang XY
Psychopharmacology (Berl); 2019 Feb; 236(2):753-762. PubMed ID: 30456540
[TBL] [Abstract][Full Text] [Related]
6. Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.
Zhang C; Zhang Y; Cai J; Chen M; Song L
Pharmacogenomics J; 2017 Jan; 17(1):92-97. PubMed ID: 26503818
[TBL] [Abstract][Full Text] [Related]
7. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients.
Hong CJ; Yu YW; Lin CH; Tsai SJ
Neurosci Lett; 2003 Oct; 349(3):206-8. PubMed ID: 12951204
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
[TBL] [Abstract][Full Text] [Related]
9. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
[TBL] [Abstract][Full Text] [Related]
10. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
[TBL] [Abstract][Full Text] [Related]
11. Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.
Tsai A; Liou YJ; Hong CJ; Wu CL; Tsai SJ; Bai YM
Neuromolecular Med; 2011 Dec; 13(4):328-33. PubMed ID: 21956459
[TBL] [Abstract][Full Text] [Related]
12. Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls.
Fang H; Zhen YF; Liu XY; Xu G; Soares JC; Zhao J; Zhang XY
Int Clin Psychopharmacol; 2016 Nov; 31(6):353-7. PubMed ID: 27483421
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine.
Ren J; Chen Y; Fang X; Wang D; Wang Y; Yu L; Wu Z; Liu R; Zhang C
Neurosci Lett; 2022 Jun; 782():136695. PubMed ID: 35618081
[TBL] [Abstract][Full Text] [Related]
14. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.
Grillo RW; Ottoni GL; Leke R; Souza DO; Portela LV; Lara DR
J Psychiatr Res; 2007; 41(1-2):31-5. PubMed ID: 16546213
[TBL] [Abstract][Full Text] [Related]
15. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
[TBL] [Abstract][Full Text] [Related]
16. Increased serum brain-derived neurotrophic factor in male schizophrenic patients with metabolic syndrome.
Lin CC; Hung YY; Tsai MC; Huang TL
Medicine (Baltimore); 2017 Jun; 96(22):e7089. PubMed ID: 28562580
[TBL] [Abstract][Full Text] [Related]
17. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
19. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia.
Eskelinen S; Sailas E; Joutsenniemi K; Holi M; Suvisaari J
Nord J Psychiatry; 2015 Jul; 69(5):339-45. PubMed ID: 25981178
[TBL] [Abstract][Full Text] [Related]
20. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
